NASDAQ · Biotechnology

CorMedix Inc. (CRMD) Stock

$7.38 +0.82% NASDAQ: CRMD Healthcare

Valuation

MetricValue
Price$7.38
Market Cap$578.97M
P/E Ratio3.01
P/B Ratio1.24
P/S Ratio1.23
EPS (TTM)$0.00
52-Week High$13.02
52-Week Low$6.13
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE44.64%
ROA20.70%
ROCE30.29%
Gross Margin85.83%
Operating Margin48.41%
Net Margin40.49%
Debt/Equity0.31
Current Ratio2.11

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$43.0M$312.0M
Operating Profit$-29.0M$-31.0M$-49.0M$-22.0M$150.0M
Net Profit$-28.0M$-30.0M$-46.0M$-18.0M$163.0M
EPS$-0.75$-0.74$-0.91$-0.30$2.04
Op Margin-15417.5%-46819.9%—-51.4%48.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$69.0M$62.0M$82.0M$119.0M$826.0M
Total Liabilities$6.0M$7.0M$12.0M$34.0M$421.0M
Cash$53.0M$43.0M$44.0M$41.0M$146.0M
Borrowings$1.0M$1.0M$1.0M$1.0M$149.0M

Latest News

Nurix Therapeutics, Inc. (NRIX) Reports Q2 Loss, Lags Revenue Estimates Zacks · Jul 9, 2026 Exelixis, Inc. (EXEL) Hit a 52 Week High, Can the Run Continue? Zacks · Jul 8, 2026 RBC Capital Trims CorMedix Price Target to $13 From $14, Maintains Outperform Rating MT Newswires · Jul 7, 2026 CorMedix Names Elizabeth Hurlburt as Chief Operating, Commercial Officer MT Newswires · Jul 2, 2026 CRMD's Growth Story Expands Beyond DefenCath Into New Trends Zacks · Jun 30, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-21.0M$-24.0M$-38.0M$-51.0M$175.0M
Investing Cash Flow$-11.0M$-4.0M$-17.0M$21.0M$-311.0M
Financing Cash Flow$0$0$0$0$-8.0M
Net Cash Flow$11.0M$-10.0M$0$-3.0M$105.0M
Free Cash Flow$-23.0M$-25.0M$-39.0M$-51.0M$173.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA1.84
FCF Yield44.19%
Quick Ratio2.36
Interest Coverage78.49
Return 1Y-30.72%
Return 3Y110.73%
Return 5Y24.92%

Ownership

Insiders Held7.53%
Institutions Held54.74%
Institutions Float Held59.19%
Institutional HolderSharesReport Date
Deep Track Capital, Lp6,274,0762026-03-31
Blackrock Inc.5,967,5752026-03-31
Vanguard Capital Management LLC3,129,6562026-03-31
State Street Corporation2,191,8432026-03-31
Royce & Associates LP1,887,5322026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About CorMedix Inc.

CorMedix Inc. is led by CEO Joseph Todisco, employs 64 people, headquartered in US, publicly traded since 2010.

CorMedix Inc. (CRMD) stock trades at $7.38 with a market capitalization of $578.97M. The stock is valued at a price-to-earnings (P/E) ratio of 3.01, price-to-book of 1.24, price-to-sales of 1.23. Over the past 52 weeks the stock has ranged between $6.13 and $13.02, and currently trades 43.3% below its 52-week high.

On profitability, CorMedix Inc. generates a return on equity (ROE) of 44.64% — well above the market average, a sign of a high-quality business, return on capital employed of 30.29%, an operating margin of 48.41%, a net profit margin of 40.49%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides